Jeffrey Trigilio - 30 Dec 2022 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Financial Officer
Signature
/s/ Jeffrey Trigilio
Issuer symbol
CGEM
Transactions as of
30 Dec 2022
Net transactions value
+$1,803
Form type
4
Filing time
06 Jan 2023, 12:48:02 UTC
Previous filing
05 Jul 2022
Next filing
21 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Award $1,803 +201 +0.49% $8.97 41,402 30 Dec 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of July 1, 2022 through December 30, 2022. This transaction is also exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on December 30, 2022.